# A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease

> **NCT01476696** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 33 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Prasugrel

## Key facts

- **NCT ID:** NCT01476696
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2014-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01476696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01476696, "A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01476696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*